Alinter Group — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Alinter Group is a private, commercial-stage pharmaceutical company with over 75 years of history, focusing on generic OTC and consumer healthcare products. Its business model centers on the manufacturing and wholesale distribution of established, fast-moving product lines such as capsules, creams, syrups, and tablets under recognized brand names like Actonorm and Histalix. The company leverages its UK manufacturing base, GMP compliance, and a group structure encompassing several subsidiary companies to serve markets in the UK, Middle East, Africa, Asia, and Europe. Its value proposition is built on quality, regulatory expertise, and providing market-ready solutions to distribution partners.

GastrointestinalCough, Cold & FluSexual DysfunctionAllergyInsomniaDermatology (Nappy Rash)Nutritional Supplements

Technology Platform

Integrated operational and regulatory platform for GMP manufacturing and wholesale distribution of generic OTC pharmaceuticals and consumer healthcare products in solid, semi-solid, and liquid dosage forms.

Opportunities

Leveraging the strong reputation of UK-manufactured pharmaceuticals to expand its network of exclusive distribution partners in growing international markets like the Middle East, Africa, and Asia.

There is further opportunity to grow its portfolio through in-licensing or acquisition of additional mature OTC brands and nutritional supplements.

Risk Factors

Key risks include regulatory compliance across multiple jurisdictions, potential supply chain disruptions, and intense competition in the OTC and generic consumer health space from larger multinational companies and low-cost producers.

The business model also carries partner dependency risk.

Competitive Landscape

Alinter Group competes in the crowded OTC and generic consumer healthcare market against large global players like Haleon, Reckitt, Perrigo, and numerous regional generic manufacturers. Its differentiation is based on UK manufacturing provenance, a portfolio of established brands, and a partnership-centric B2B wholesale model rather than direct consumer marketing.

More companies in Small Molecule Drugs →More companies in United Kingdom →